 OraSure Technologies Inc NASDAQ: OSUR has resubmitted two separate Emergency Use Authorization EUA applications for its SARS-CoV-2 Antibody ELISA and the oral specimen collection device. ELISA is intended to qualitatively detect total antibodies to SARS-CoV-2 in human oral fluid specimens collected with the OraSure Oral Antibody Collection Device. 